SOURCE: Elsevier Business Intelligence

Elsevier Business Intelligence

February 29, 2012 16:58 ET

Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 London', April 25-26, 2012

LONDON--(Marketwire - Feb 29, 2012) - Elsevier Business Intelligence, the medtech industry's leading provider of strategic partnership and investment conferences, announced today that it will host the 'IN3 Medical Device 360° London' investor conference on April 25-26, 2012, at the Millennium Gloucester Hotel & Conference Centre London.

The Investment in Innovation (IN3) Medical Device 360° London conference will feature presentations by more than 20 early-, mid- and late-stage start-up companies that are seeking funding and/or strategic partnership across the spectrum of diagnostic and therapeutic device markets. The conference also will feature an outstanding agenda of panels, networking sessions and meet-and-greets with industry thought leaders discussing the most pressing issues facing the global device industry in 2012 and beyond. Participating speakers confirmed to date include senior-level investors from Covidien, Delta Partners, Earlybird Venture Capital, Edwards Lifesciences, Forbion, Fountain Healthcare Partners, Gilde Healthcare Partners, Family Office Fund, NBGI Ventures, Peppermint VP, Philips, Seroba Bioventures, Sofinnova Partners, Sorin Group, Stryker, Wellington Partners, and many more. Panel topics will include: what corporate buyers are looking for in 2012; what venture dealmakers are looking for in emerging med device companies; the shift toward overseas clinical trials; and other timely topics. In addition, large company/VC meet-and-greets will be held to facilitate interaction between these two influential groups and conference participants. Partnering software will be available to all registered attendees prior to the conference so that one-on-one onsite meetings can be pre-arranged.

This two-day special event will benefit a wide variety of participants in the medical device sector: start-ups seeking investment or strategic partnerships, investment firms, VCs, mid-size and large medical device manufacturers, and service providers. Emerging medtech companies that would like to apply to present in London should contact Kayleen Kell at 949-797-7142, or email k.kell@elsevier.com.

IN3 Medical Device 360° London will be held at the Millennium Gloucester Hotel & Conference Centre London. Event co-sponsors to date include Ronald Trahan Associates Inc., Aptiv Solutions, Marketwire, Mass Medical Angels and Life Science Intelligence and Scisive Consulting LP. Visit www.IN3London.com for full conference and registration details. EBI will be hosting two additional IN3 Medical Device 360° events in 2012, in Boston and San Francisco; visit www.elsevierbi.com/conferences for more information.

About Elsevier Business Intelligence
Elsevier Business Intelligence (EBI), an Elsevier company built on the heritage of F-D-C Reports, Windhover Information and Medtech Insight, is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, databases and reports, EBI places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis. EBI (www.elsevierbi.com) has offices in the U.S. in Bridgewater, N.J.; Norwalk, Conn.; Rockville, Md.; and Irvine, Calif.

Contact Information

  • Contact:
    Ronald Trahan, APR
    Ronald Trahan Associates Inc.
    508-359-4005, x108